Cancer is a scary word. Truth is, it’s even more frightening in reality than the word can convey.
I was trained to complete a head and neck oral cancer screening 26 years ago in dental school and have
been doing them routinely ever since. The problem is that head and neck cancer hasn’t stayed the same
in those 26 years, so why should our detection and screening not advance to meet the challenge?
Approximately 42,000 people in the U.S. were diagnosed
with oral cancer in 2013 and expectations are the number will
rise to between 43,000 and 45,000 in 2014, according the Oral
Cancer Foundation. Oral cancers include those cancers that
occur in the mouth itself, those on the exterior lip of the mouth,
and those in the oropharynx, oropharyngeal cancers. The number
of oral cancer diagnoses has been on a steady rise for the past
five years, and 2007 saw the greatest single increase in incidence
rates of over 11 percent. To put these numbers into perspective,
100 people will be diagnosed with oral cancer everyday in the
U.S., and once every hour someone dies from this disease.
So what do we know about cancer? There are two major
etiologies in patients with cancer. Traditionally, tumors were
caused by environmental factors (smoking and drinking),
immunosuppression (congenital, HIV and transplantation),
severe vitamin deficiencies, poor oral hygiene and nutrition,
syphilis and radiation therapy. More recently human papilloma
virus (HPV) has caused a paradigm shift in this disease. HPV,
cervical cancer in women and is causing oropharyngeal cancers
in both sexes. A small percentage of people (less than 7 percent)
do get oral cancers from unidentified causes. It is currently
believed these are likely related to some genetic predisposition.
The incidence of classic head and neck cancers is decreasing,
but HPV-related head and neck cancers are increasing. Between
1988 and 2008 there has been more than a 200 percent increase.
Consider that it is estimated about
80 percent of the adult male population
has been exposed to HPV.Most people with healthy immune
systems clear the virus within 24
months of exposure, however, in
some people the virus can lie dormant
for decades before progressing
to cancer.
The survival rate for oral cancer is vastly different depending on
when it is detected. When found at early stages (Stage I and II) of
development, oral cancers have an 80 to 90 percent survival rate.
Early stage detection also allows for less invasive, less life-devastating
treatments. Unfortunately most oral cancer isn’t detected until
in the late stages (Stage III and IV), and this accounts for the very
high death rate of about 43 percent at five years from diagnosis.
Late stage diagnosis also can necessitate traditional treatments like
surgery and radiation therapy and high treatment-related morbidity
in patients who survive the cancer. Late stage diagnosis is not
occurring because most of these cancers are hard to discover; rather
it is because of a lack of public awareness. Dentistry has the opportunity
to change this and save lives.
About a year ago two events made me decide I needed to
increase our ability to diagnose oropharyngeal cancer for our
patients. The first was a patient with cancer. We did not find
Dan’s cancer at a dental visit, it was found only once he had difficulty
swallowing. I partnered with him before he began his
treatment to help prepare him for the dental consequences and
try to prevent massive damage to his teeth. Over the course of his
medical treatment I watched as he couldn’t eat or even brush his
teeth because his oral tissues were so painful. We worked together
to think of ways he could keep his mouth clean, manage the
burning tissues and improve his quality of life. Just when we
thought we were on the other side, the next phase of challenges
emerged. Radiographs had documented incredible external root
resorption that would most likely cost him most of his posterior
teeth on the side where he received his radiation therapy.
The second instrumental event was attending a lecture by Dr.
Ted Teknos on oropharyngeal cancer. I learned much about the
disease, its progression and treatment, but that is not what I left
with. The message I took away was the need for awareness on the part of our patients about the risks, and the gift of early detection.
The first change we made in our office was to be an advocate
for our patients to understand what oral cancer is and that it
can be found early and then treated successfully. This began by
explaining to patients why we have always done such a thorough
head and neck screening and what we are looking for. Patient
information grew by adding pamphlets on oral cancer and information
to the patient education slideshow that plays in our
reception room. Helping our patients become aware was an
important first step, but fulfilling on the promise of making a difference
meant finding out how to get better at early detection.
My research ended with a decision to acquire a VELscope for
our office and have every team member complete the training. I
have a very basic paradigm when it comes to new technology or
materials in my practice. First and foremost it has to effectively
and efficiently provide the top quality of care for my patients.
When it comes to efficiency, VELscope does not require the use
of rinses, dyes or extended time to complete. The VELscope
works by emitting a safe, visible blue light that causes the oral
tissues to fluoresce.
Oral tissues contain “fluorophones” which are excited by a
blue light of an appropriate wavelength and then emit their
own light at a different wavelength, causing them to look predominantly
green. Healthy tissue has its own particular pattern
or appearance with fluorescence, which is strongly affected by
abnormal processes that result from tissue injury or disease.
The resulting abnormal fluorescence appearance (typically presenting
as a marked and unusual loss of fluorescence) is often
more dramatic and easily visible than the changes observed
with conventional illumination. The VELscope helps me
detect abnormal areas requiring follow-up that we might otherwise
have missed had we performed only the traditional head
and neck exam.
In just a few minutes during a hygiene exam we complete a
VElscope exam in addition to our traditional head and neck
screening. We put a pair of orange glasses on the patient and dim
the lights in the room. With a clean shield on the VELscope we
look through it and activate the light. Through the lens of the
VELscope we examine all of the oral tissues, base of the tongue
and as far back in the throat as we can visualize. With training and experience, we have a good sense of what type of fluorescence
pattern is indicative of normal tissue or a normal variation.
Tissue that has an unusual appearance through the VELscope,
such as a pronounced loss of fluorescence in an area of the
mouth that typically presents as a bright green, will get our
attention. We are particularly concerned about abnormal areas
for which we have no plausible explanation.
Inflammation associated with tissue injury or infection will
almost always display a loss of fluorescence and so we can use a
blanching technique to help us characterize these areas. When
tissues blanch under diascopic pressure, it indicates that inflammation
is present. In such cases, we try to ascertain the cause of
the inflammation, deal with it if possible and have the patient
return for a post op check in 14 days to make sure that the area
has resolved. Abnormal areas with an unknown cause which
persist despite our best efforts to deal with a possible cause are
referred to a specialist for further evaluation.
Fortunately we have only had to refer about four patients, but
more fortunately the three whose diagnosis was cancer were
caught early enough that the prognosis is excellent. Every time
we finish a head and neck exam and VELscope exam with no
findings, we breathe a sigh of relief, and each time we find something
I am glad that we may have helped spare a patient from the
aggressive and debilitating treatment I watched Dan go through.
The death rates from oral cancer do not have to continue to
rise, and we have the ability to help create awareness in this country,
one patient at a time in our offices. As dental professionals,
we are a key to both early detection of this disease and to aiding
with the side effects (xerostomia, destruction of the dentition,
etc.) for patients undergoing cancer treatment. Early detection is
time well spent versus sitting with patients having difficult conversations
about how we can support them through aggressive
treatment. However you decide to make a difference, be an advocate
for stopping this disease.
|